Skip to content
healthcare.dev

PLUVICTO

NDC 0078-1217, lutetium Lu 177 vipivotide tetraxetan, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-1217
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215833
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1217 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN27 mCi/mL

Pharmacologic classes

Radioligand Activity [MoA]; Radioligand Therapeutic Agent [EPC]

Package NDCNDC-11Package
0078-1217-61000781217611 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14908037-2892-4d98-a053-253ce35afb1a

Use it

Look up 0078-1217 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1217 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-1217. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.